HighVista Strategies’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-10,226
| Closed | -$345K | – | 132 |
|
|
2021
Q1 | $345K | Sell |
10,226
-5,164
| -34% | -$174K | 0.26% | 74 |
|
|
2020
Q4 | $537K | Buy |
15,390
+1,190
| +8% | +$41.5K | 0.34% | 66 |
|
|
2020
Q3 | $493K | Sell |
14,200
-600
| -4% | -$20.8K | 0.36% | 50 |
|
|
2020
Q2 | $485K | Sell |
14,800
-3,800
| -20% | -$125K | 0.4% | 27 |
|
|
2020
Q1 | $560K | Sell |
18,600
-35,200
| -65% | -$1.06M | 0.52% | 20 |
|
|
2019
Q4 | $1.56M | Sell |
53,800
-23,000
| -30% | -$666K | 1.18% | 25 |
|
|
2019
Q3 | $1.99M | Buy |
76,800
+7,800
| +11% | +$202K | 1.35% | 24 |
|
|
2019
Q2 | $1.76M | Sell |
69,000
-5,800
| -8% | -$148K | 0.9% | 26 |
|
|
2019
Q1 | $1.96M | Sell |
74,800
-10,200
| -12% | -$267K | 1.6% | 24 |
|
|
2018
Q4 | $1.96M | Sell |
85,000
-24,200
| -22% | -$557K | 1.69% | 19 |
|
|
2018
Q3 | $2.57M | Buy |
109,200
+9,600
| +10% | +$226K | 1.2% | 22 |
|
|
2018
Q2 | $2.3M | Buy |
99,600
+34,200
| +52% | +$789K | 1.04% | 23 |
|
|
2018
Q1 | $1.61M | Buy |
65,400
+2,600
| +4% | +$64K | 0.69% | 25 |
|
|
2017
Q4 | $1.69M | Buy |
+62,800
| New | +$1.69M | 0.47% | 50 |
|
|
2015
Q4 | – | Sell |
-115,234
| Closed | -$3.13M | – | 223 |
|
|
2015
Q3 | $3.13M | Sell |
115,234
-11,318
| -9% | -$307K | 0.59% | 83 |
|
|
2015
Q2 | $3.47M | Sell |
126,552
-30,892
| -20% | -$846K | 0.59% | 80 |
|
|
2015
Q1 | $4.2M | Buy |
+157,444
| New | +$4.2M | 0.67% | 72 |
|